At its last Claims WG meeting on 8 January 2025, the European Food Safety Authority (EFSA) discussed several health claims applications in the pipeline:
Cranberry Powder and Urinary Tract Health The WG discussed the reply from the applicant to the second stop-clock letter and agreed on the conclusions. The draft opinion will most likely now be submitted to the EFSA NDA Panel for discussion and possible adoption.
Olive Oil Polyphenols and cholesterol levels The WG discussed replies to the first stop-clock letters related to two applications:
Maintenance of normal HDL-cholesterol concentrations
Reduction of LDL-cholesterol and systolic blood pressure (SBP), risk factors for coronary heart disease
Echinacea with unique alkamides for reducing subthreshold anxiety The dossier was validated for further WG discussion.